Datwyler

https://www.pharmtech.com/pt_w/sterilization

Choosing the right sterilization technique for your drug product and its packaging is not always a simple decision. While most packaged drug products have specific requirements, newer sterilization techniques offer innovative ways of ensuring sterility that may be more suitable than standard sterilization processes. In this webcast, the audience will learn about standard sterilization processes, be introduced to newer techniques, and understand how these techniques have been applied to parenteral packaging components.

Understand traditional sterilization techniques and their applications to parenteral packaging

Recognize the challenges of sterilizing certain packaging components and how to mitigate these issues for successful sterility

Learn new sterilization processes, such as X-ray and chlorine dioxide, and understand their benefits from relevant case studies

Quality/regulatory personnel in parenteral drug delivery

Formulation scientists and packaging engineers

Device development engineers and managers

Technical functions surrounding drug delivery systems

Manager Surface Developments Healthcare in R&D
Datwyler

Webcasts

Thursday, September 16, 2021 at 10am EDT| 7am PDT| 3pm BST| 4pm CEST

Choosing the right sterilization technique for your drug product and its packaging is not always a simple decision. Join the webcast on September 15th to learn about standard sterilization processes, be introduced to newer techniques, and understand how these techniques have been applied to parenteral packaging components.

Sterilization Techniques for Parenteral Packaging

https://www.pharmtech.com/pt_w/cartridges

As drug companies seek innovative ways to improve the delivery of drugs and patient compliance, the demand for cartridge-based drug delivery devices— such as pen injectors and on-body injectors—has increased. As new devices and delivery methods become available, it is important that device and drug developers have a wide selection of parenteral packaging for these cartridge applications, as well as an understanding of the components and applications.

This webcast will introduce the audience to packaging components for cartridges used in drug delivery devices today and explore future trends that are emerging in the market.

An introduction to parenteral packaging for cartridges used in drug delivery devices

An overview of common challenges in the market, featuring case studies on packaging drug delivery devices

A look at emerging drug delivery trends, such as large-volume, on-body injectors

Understand the common cartridge applications for drug delivery devices available on the market today

Learn through case studies and best practices what parenteral packaging components are available for these applications and how to select the ideal cartridge components

Understand future trends for drug delivery devices and how parenteral packaging suppliers are working to meet future market needs


Tuesday, June 22, 2021 10am EDT| 7am PDT| 3pm BST| 4pm CEST

*Tuesday, June 22, 2021 10am EDT| 7am PDT| 3pm BST| 4pm CEST* Over the past few years, the use of drug delivery devices has steadily increased, leading to a higher demand for cartridges. This webcast will introduce the audience to packaging components for cartridges used in drug delivery devices today and explore future trends that are emerging in the market. *On Demand Until June 22, 2022*

Parenteral Packaging for Cartridges in Drug Delivery Devices

For drug developers, being ready to develop and mass produce drugs for a pandemic situation is an essential part of their risk management strategy. But what about the packaging suppliers that create containers, stoppers, plungers, and seals to protect and deliver these vital drugs?

This webinar will discuss work that has been done to develop, manufacture, and distribute parenteral packaging components for the on-going COVID-19 pandemic, while also touching on the critical aspects to consider to prepare for a future pandemic or natural disaster scenario.

An introduction to packaging components for vaccine applications

An overview of common challenges that packaging suppliers face with manufacturing and distributing vaccines and how to overcome them

Strategies for ensuring business continuity during disaster scenarios

Understand the risks that the pharma industry faces when it comes to packaging vaccines in emergency scenarios and which actions to take to mitigate these risks.

Learn steps to take to overcome manufacturing and distribution challenges for vaccine components.

Learn from case studies and best practices about how to ensure business continuity during disaster scenarios .

: Geert Moens, Global Platform Leader, Vial Closure Systems

: Thursday, March 25, 2021, 10am EDT| 7am PDT| 3pm GMT | 4pm CET

On demand available after final airing until March 25, 2022

***Live: Thursday, March 25, 2021, 10am EDT| 7am PDT| 3pm GMT | 4pm CET*** For vaccine developers, the COVID-19 pandemic has posed challenges for packaging and distributing life-saving drug products. In this webcast, learn how parenteral packaging suppliers are ready to help vaccine developers overcome these challenges and prepare for future pandemic scenarios. *** On demand available after final airing until March 25, 2022.***


Pandemic Preparedness: Ensuring a Robust Parenteral Packaging Supply Chain 

http://www.pharmtech.com/pt_w/design_principles


	Parenteral drug developers are faced with multiple challenges when it comes to packaging drug products; one of the most critical is protecting the drug product from particulate matter. Particulates pose a risk to the overall quality and effectiveness of the drug, causing contaminated products to be discarded during manufacturing, or, in a worst-case scenario, during a recall event. To prevent these costly scenarios, it is imperative that measures are put into place to analyze, quantify, and mitigate particulate matter in drug product packaging.

	This webcast will include a discussion of the following:

		Common concerns in the industry, specifically regarding particulate matter in parenteral packaging

		Quality principles and how they are applied to the analysis and quantification of particulate matter

		How to implement processes in the design, manufacturing, and testing of parenteral packaging to mitigate the risk of particulate exposure

		Understand the risks that face the pharmaceutical industry today regarding particulate matter

		Introduce the quality principles used to analyze and quantify particulate matter

		Review key findings and best practices for identifying and reducing particulate matter in parenteral packaging

Gert Gregoire, Global Process Engineering Manager, Datwyler Sealing Solutions

Part III: Tuesday, Oct. 20, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST

	On demand available after airing until Oct. 20, 2021

Do you have concerns about particulate matter entering your parenteral drug product? Register for the Oct. 20 webcast, “Using Quality Principles to Analyze and Quantify Particulate Matter in Parenteral Packaging”. This webcast is part of a series focusing on The Path to Patient Safety: Addressing Industry Concerns and Solutions for Primary Packaging Component Selection.

Live: Part III: Tuesday, Oct. 20, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST

On demand available after airing until Oct. 20, 2021

Register free



Using Quality Principles to Analyze and Quantify Particulate Matter in Parenteral Packaging

	In today’s regulatory environment, stricter requirements are being placed on primary packaging components for parenteral drug products. Packaging suppliers are making efforts to meet these requirements in order to ensure their products are accepted by both regulatory bodies and pharmaceutical companies. This webcast will analyze 

 General Chapters <381> and <382> and discuss ways to not only meet the regulatory requirements currently in place, but to exceed them with an effort to create a future-proof regulatory pathway.

 General Chapter <381>, “Elastomeric Components in Injectable Pharmaceutical Product Packaging/Delivery Systems”

 General Chapter<382>, “Elastomeric Component Functional Suitability in Parenteral Packaging/Delivery Systems”

		A discussion of the best practices for meeting current industry requirements currently for elastomeric primary packaging

		Using industry trends, a look to the future of regulatory requirements for elastomeric components, as well as the presentation of a future-proof strategy to ensure standards are met over time

			Understand the risks that face the pharmaceutical industry today regarding stricter and evolving regulatory requirements

			Introduce the requirements and understand the implications of 

 <381> and <382> for elastomeric components

			Review future trends and how to prepare for regulatory changes over time

Renaud Janssen, Vice President Technical Services, Datwyler

Part II: Wednesday, Jul. 22, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST

	On demand available after airing until Jul.22, 2021

Interested in learning more about the regulatory requirements for elastomeric components in parenteral drug packaging? Sign up for the July 22 webcast on “Best Practices for Meeting and Exceeding Regulatory Standards in Primary Packaging USP  and ” . This webcast is part of a series focusing on “The Path to Patient Safety – Addressing Industry Concerns and Solutions for Primary Packaging Component Selection.” 
Live: Part II: Wednesday, Jul. 22, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST
On demand available after airing until Jul. 22, 2021
Register free



Best Practices for Meeting and Exceeding Regulatory Standards in Primary Packaging USP  and 

	Visible particles are a concern for the pharmaceutical industry. In the last few years, a quarter of all sterile injectable drug recalls were linked to particulate found in finished drugs. This poses a significant challenge to address quality requirements and to comply with regulatory authorities in various geo-regions. This webcast will focus on innovations in the manufacturing of parenteral packaging components to address the demanding needs for packaging sensitive drugs, such as biologics.

		Common concerns in the pharmaceutical industry surrounding parenteral packaging

		A quality-by-design approach to manufacturing components to mitigate industry concerns that relate to particulates and silicone contamination

		Analytical tools utilized to ensure packaging integrity and product quality

		Advancements in products and processes to achieve best-in-class specifications, with a focus on 'zero-defects'

			Understand the risks that face the pharmaceutical industry today from a drug packaging perspective, and discuss strategies to mitigate these risks

			Introduce a QbD approach to product manufacturing and product design for pharmaceutical components with a focus on particulate reduction

			Review solutions for manufacturing high-quality packaging components to meet the needs of biologics and sensitive molecules

Rahul Thakar, PhD, Technical Key Account Manager, Datwyler

	Elke Geuzens, Technical Key Account Manager, Datwyler

Part I: Tuesday, Apr. 7, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST

	On demand available after airing until Apr. 7, 2021

Join us on April 7th, for part one out of our three-part series, which will focus on innovations in the manufacturing of parenteral packaging components to address the demanding needs for packaging sensitive drugs, such as biologics. 
Live: Part I: Tuesday, Apr. 7, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST
On demand available after airing until Apr. 7, 2021
Register free



Striving for Zero Defects: Use of Quality-by-Design Principles for Manufacturing Parenteral Packaging Components to Mitigate Risks of Drug Product Contamination

Datwyler

Articles